ArticleAvicenna journal of phytomedicine

Wortmannin exhibits anticancer activity in oral cancer cell line by targeting PI3K, AKT and mTOR pathway.

Gauri Kumbhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.